Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer.

Hu X, Li YQ, Li QG, Ma YL, Peng JJ, Cai SJ.

EBioMedicine. 2018 Sep;35:178-188. doi: 10.1016/j.ebiom.2018.08.003. Epub 2018 Aug 9.

2.

CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.

Workel HH, Komdeur FL, Wouters MC, Plat A, Klip HG, Eggink FA, Wisman GB, Arts HJ, Oonk MH, Mourits MJ, Yigit R, Versluis M, Duiker EW, Hollema H, de Bruyn M, Nijman HW.

Eur J Cancer. 2016 Jun;60:1-11. doi: 10.1016/j.ejca.2016.02.026. Epub 2016 Mar 31.

PMID:
27038842
3.

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.

Komdeur FL, Prins TM, van de Wall S, Plat A, Wisman GBA, Hollema H, Daemen T, Church DN, de Bruyn M, Nijman HW.

Oncoimmunology. 2017 Jul 24;6(9):e1338230. doi: 10.1080/2162402X.2017.1338230. eCollection 2017.

4.

Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer.

Hu X, Li YQ, Li QG, Ma YL, Peng JJ, Cai SJ.

EBioMedicine. 2018 Aug;34:35-45. doi: 10.1016/j.ebiom.2018.07.021. Epub 2018 Jul 21.

5.

Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.

Li Y, Liang L, Dai W, Cai G, Xu Y, Li X, Li Q, Cai S.

Mol Cancer. 2016 Aug 24;15(1):55. doi: 10.1186/s12943-016-0539-x.

6.

Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ.

Koch M, Beckhove P, Op den Winkel J, Autenrieth D, Wagner P, Nummer D, Specht S, Antolovic D, Galindo L, Schmitz-Winnenthal FH, Schirrmacher V, Büchler MW, Weitz J.

Ann Surg. 2006 Dec;244(6):986-92; discussion 992-3.

7.

Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.

de Jong RA, Leffers N, Boezen HM, ten Hoor KA, van der Zee AG, Hollema H, Nijman HW.

Gynecol Oncol. 2009 Jul;114(1):105-10. doi: 10.1016/j.ygyno.2009.03.022. Epub 2009 May 2.

PMID:
19411095
8.

Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.

Deschoolmeester V, Baay M, Van Marck E, Weyler J, Vermeulen P, Lardon F, Vermorken JB.

BMC Immunol. 2010 Apr 12;11:19. doi: 10.1186/1471-2172-11-19.

9.

OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.

Weixler B, Cremonesi E, Sorge R, Muraro MG, Delko T, Nebiker CA, Däster S, Governa V, Amicarella F, Soysal SD, Kettelhack C, von Holzen UW, Eppenberger-Castori S, Spagnoli GC, Oertli D, Iezzi G, Terracciano L, Tornillo L, Sconocchia G, Droeser RA.

Oncotarget. 2015 Nov 10;6(35):37588-99. doi: 10.18632/oncotarget.5940.

10.

In situ localization of tumor cells associated with the epithelial-mesenchymal transition marker Snail and the prognostic impact of lymphocytes in the tumor microenvironment in invasive ductal breast cancer.

Alkatout I, Hübner F, Wenners A, Hedderich J, Wiedermann M, Sánchez C, Röcken C, Mathiak M, Maass N, Klapper W.

Exp Mol Pathol. 2017 Apr;102(2):268-275. doi: 10.1016/j.yexmp.2017.02.013. Epub 2017 Feb 21.

PMID:
28232080
11.

Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma.

Li S, Xu F, Zhang J, Wang L, Zheng Y, Wu X, Wang J, Huang Q, Lai M.

Oncoimmunology. 2017 Oct 11;7(2):e1380765. doi: 10.1080/2162402X.2017.1380765. eCollection 2018.

12.

Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.

Katz SC, Bamboat ZM, Maker AV, Shia J, Pillarisetty VG, Yopp AC, Hedvat CV, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, DeMatteo RP.

Ann Surg Oncol. 2013 Mar;20(3):946-55. doi: 10.1245/s10434-012-2668-9. Epub 2012 Sep 26.

13.

Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.

Wagner P, Koch M, Nummer D, Palm S, Galindo L, Autenrieth D, Rahbari N, Schmitz-Winnenthal FH, Schirrmacher V, Büchler MW, Beckhove P, Weitz J.

Ann Surg Oncol. 2008 Aug;15(8):2310-7. doi: 10.1245/s10434-008-9971-5. Epub 2008 Jun 3. Erratum in: Ann Surg Oncol. 2009 Apr;16(4):1084. Rahbari, Nuh [added].

PMID:
18521684
14.

Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.

Kwak Y, Koh J, Kim DW, Kang SB, Kim WH, Lee HS.

Oncotarget. 2016 Dec 6;7(49):81778-81790. doi: 10.18632/oncotarget.13207.

15.

Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.

Baxevanis CN, Dedoussis GV, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M.

Cancer. 1994 Aug 15;74(4):1275-82.

PMID:
7914469
16.

The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.

Ohta M, Tanaka F, Yamaguchi H, Sadanaga N, Inoue H, Mori M.

Int J Oncol. 2005 Jan;26(1):41-7.

PMID:
15586223
17.

Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse.

Nardone V, Botta C, Caraglia M, Martino EC, Ambrosio MR, Carfagno T, Tini P, Semeraro L, Misso G, Grimaldi A, Boccellino M, Facchini G, Berretta M, Vischi G, Rocca BJ, Barone A, Tassone P, Tagliaferri P, Del Vecchio MT, Pirtoli L, Correale P.

Cancer Biol Ther. 2016 Nov;17(11):1213-1220.

18.

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.

Liu S, Lachapelle J, Leung S, Gao D, Foulkes WD, Nielsen TO.

Breast Cancer Res. 2012 Mar 15;14(2):R48.

19.

The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer.

Väyrynen JP, Kantola T, Väyrynen SA, Klintrup K, Bloigu R, Karhu T, Mäkelä J, Herzig KH, Karttunen TJ, Tuomisto A, Mäkinen MJ.

Int J Cancer. 2016 Jul 1;139(1):112-21. doi: 10.1002/ijc.30040. Epub 2016 Mar 7.

20.

Supplemental Content

Support Center